Commit To Buy OncoMed Pharmaceuticals At $2.50, Earn 6.6% Annualized Using Options
May 08, 2017 at 11:49 AM EDT
Investors considering a purchase of OncoMed Pharmaceuticals Inc. (OMED) stock, but cautious about paying the going market price of $3.66/share, might benefit from considering selling puts among the alternative strategies at their disposal..
